Author

Wei Bu

National Institutes of HealthORCID 0000-0002-1747-4945Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Research Focus:metabolism & bioenergetics· 1 Organism:non-human primate· 1

Frequent Co-Authors

Alexander C VostaliD· 1 shared Andreas MargrafiD· 1 shared Ayda Henriques SchneideriD· 1 shared Chiara CecconelloiD· 1 shared Dawid MaciorowskiiD· 1 shared Dianne CooperiD· 1 shared Duco Steven KoenisiD· 1 shared Forrest H. HoytiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alexander C VostalORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Immunization With Herpes Simplex Virus Nanoparticles Targeting Both Attachment and Fusion Protect Against Infection

Dawid Maciorowski, Alexander C Vostal, Wei Bu, Isabella S. Pytel, Sophia Antonioli-Schmit, Jianghai Zhu, Forrest H. Hoyt, Haotian Lei, Guangping Liu, Kristen Kaiser, Richard Herbert, Kennichi Dowdell, John T. Schiller, Kening Wang, Mark R. Howarth, Jeffrey I. Cohen

This study develops HSV-2 nanoparticles targeting both gD and gH/gL, showing that combined immunization provides robust protection through complementary mechanisms beyond neutralization.

bioRxiv · Apr 29, 2026 · PreprintImmunology

Formyl-peptide receptor type 2 activation mitigates secondary organ damage in inflammatory arthritis

Andreas Margraf, Jianmin Chen, Marilena Christoforou, Pol Claria-Ribas, Ayda Henriques Schneider, Chiara Cecconello, Wei Bu, Paul R. C. Imbert, Thomas D Wright, Stefan Russo, Isobel Alice Blacksell, Duco Steven Koenis, Jesmond Dalli, John A. Lupisella, Nicholas R. Wurtz, , Mauro Perretti

This study shows that activating FPR2 with a small molecule agonist reduces cardiac and lung damage in arthritic mice by decreasing inflammation and fibrosis.

bioRxiv · Feb 3, 2025 · PreprintPharmacology & Toxicology